ProMIS Neurosciences to participate in September conferences and events
ProMIS Neurosciences Inc. (PMN) announced it will participate in upcoming conferences and events in September.
CAMBRIDGE, Mass, Sept.
01, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc.
NASDAQ:PMN, a clinical-stage biotechnology company developing antibody therapeutics and vaccines targeting toxic misfolded proteins in neurodegenerative diseases, today announced that it will participate in upcoming Septe…